• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > LMB News > Lalita Ramakrishnan elected to prestigious fellowships

Lalita Ramakrishnan elected to prestigious fellowships

Published on 11 May, 2018

Lalita RamakrishnanLalita Ramakrishnan, group leader in the University of Cambridge Molecular Immunity Unit, which is housed at the LMB, has been elected to the fellowship of the Academy of Medical Sciences and to The Royal Society.

The Academy of Medical Sciences represents the diverse spectrum of medical science – from basic research through clinical application to healthcare delivery. Their mission is to promote medical science and its translation into benefits for society. Academy Fellows are elected based on excellence in medical research, their contribution to medicine and society and are drawn from a range of professions.

The Royal Society is a Fellowship of the world’s most eminent scientists and is the oldest scientific academy in continuous existence. It seeks to promote excellence in science, electing up to fifty-two new Fellows and up to ten new Foreign Members each year who have made substantial contributions to the improvement of knowledge in the sciences.

Lalita’s research focuses on understanding the mechanisms by which Mycobacterium causes tuberculosis (TB), and why different people have vastly different susceptibilities to the disease. The group has developed the zebrafish as a model to study immunity to tuberculosis – zebrafish are transparent meaning that the infection process in them can be monitored in real time. In addition, genetic tools have enabled the group to understand the basis of host resistance and susceptibility to TB. Lalita’s research is shedding light on how TB causes disease as well as fundamental mechanisms of immune cell chemotaxis, adhesion, aggregation and immune regulation. Findings made in the zebrafish have been borne out in human populations and are informing new strategies for intervention

The LMB congratulates Lalita on her achievement which is foremost a recognition of the importance of her group’s work on the pathology of tuberculosis but also of the importance of microbiology and the work of the Molecular Immunity Unit.

Further references

Lalita’s group page
Molecular Immunity Unit
The Academy of Medical Sciences
The Royal Society

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed. Ok